International Journal of Radiation Oncology*Biology*Physics
Oral Scientific SessionsHigher Radiation Dose to Immune System is Correlated With Poorer Survival in Patients With Stage III Non–small Cell Lung Cancer: A Secondary Study of a Phase 3 Cooperative Group Trial (NRG Oncology RTOG 0617)
Cited by (0)
Author Disclosure: J. Jin: Research Grant; Xstrahl Inc., Varian Medical System, NIH. Honoraria; Varian Medical system. C. Hu: Research Grant; NCI. Honoraria; Varian. Y. Xiao: None. H. Zhang: None. S. Ellsworth: None. S.E. Schild: Research Grant; Alliance. Travel Expenses; Alliance. J.A. Bogart: Partner; Upstate University Radiation Oncology. Travel Expenses; Alliance Clinical Trials. Chair, radiation oncology committee; Alliance. M.C. Dobelbower: Honoraria; Varian Medical Systems. Oversee operations; Alabama Cancer Congress president. V.S. Kavadi: Partner; Texas Oncology. Medical Director; US Oncology; US Oncology. S. Narayan: None. P. Iyengar: None. C.G. Robinson: Research Grant; Elekta, Varian Medical Systems. Speaker's Bureau; DFINE, Varian Medical Systems. Advisory Board; Radialogica. Travel Expenses; DFINE, Varian Medical Systems. Stock Options; Radialogica. A.M. Brufsky: None. C.D. Koprowski: None. M. Machtay: Research Grant; AbbVie. Consultant; AbbVie, Stemnion Inc. Advisory Board; Stemnion Inc.; NRG Oncology Group, RTOG Foundation. W.J. Curran: ASCO. R. Paulus: None. H. Choy: Research Grant; Celegene. Advisory Board; Bayer, EMD. J.D. Bradley: None. F. Kong: Research Grant; NCI/NIH, Varian.; Sino-American Network for Therapeutic Radiology, American Association of Women Radiologists (AAWR), Association for Chinese Professors, Chinese-American Network for Hematology and Oncolo, Sino-American Network for Therapeutic Radiation Oncology.